January 26, 2024 Experience China National Petroleum RMB1 billion guaranteed bonds offering We advised CNPC on the offering
December 29, 2023 Experience Modern Land (China) consent solicitation The consent solicitation included multiple tranches of outstanding senior notes
December 26, 2023 Experience HighTide Therapeutics HK$194.1 million IPO We advised HighTide Therapeutics on its IPO and HKEX listing
December 15, 2023 Experience Zhejiang Expressway $860 million rights issue The H shares are listed on the Hong Kong Stock Exchange
December 11, 2023 Experience Atour Lifestyle Holdings $174.4 million secondary offering We advised Atour on a secondary offering of ADSs
December 8, 2023 Experience Innovent Biologics HK$2.4 billion placement of shares The shares are listed on the Hong Kong Stock Exchange
December 7, 2023 Experience Weibo concurrent $330 million convertible notes and $63.5 million ADS offerings The company also entered into an ADS lending agreement in connection with the ADS offering
December 4, 2023 Experience Tencent $100 million strategic investment in Global Blue Group Holding We advised Tencent on the transaction
August 10, 2023 Experience Gracell Biotechnologies PIPE of ordinary shares and warrants The company’s ADSs are listed on Nasdaq